ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

Integrated software, AI-driven analytics, and frictionless workflows enable customers to harness the full power of biological insights SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ...

We resent it when preliminary or ancillary work occupies so much of our attention that our real work, or what we consider to be our real work, recedes. No less a figure than Enrico Fermi, when ...

ARK Invest’s multiomics analyst, Nemo M Despot, and the firm’s leader, Cathie Wood, have hinted at a revolutionary approach to healthcare, leveraging multiomics, artificial intelligence, and big data.

Learn how to leverage the power of multiomics without the steep learning curve of bioinformatics. With intuitive interfaces and powerful analytical tools, you can unlock comprehensive biological ...

Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University School of Medicine have developed software to help scientists more easily analyze ...

Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ...

Precision oncology company Orakl Oncology (Villejuif, France) has raised €11 million in seed funding to enable it to begin marketing its first two AI-powered products for oncology drug development, ...

IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion Healthcare and Life Sciences Industry SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) ...